Algenex is a private biotech company with proprietary and patented technologies to boost the production of recombinant proteins using BVES in insect cells.
Location: Spain, Community of Madrid, Húmera
Employees: 11-50
Total raised: $4.53M
Founded date: 2005
Investors 1
| Date | Name | Website |
| - | Cleon Capi... | cleoncapit... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 06.03.2019 | - | $4.53M | - |
Mentions in press and media 7
| Date | Title | Description |
| 20.03.2023 | Exclusive: Cocoon Bioscience closes $16m round to turn moths into bioreactors for cultivated meat | Cocoon Bioscience has closed a €15 million ($15.9 million) round to grow its high-value proteins business, which includes developing recombinant proteins for cultivated meat growth media. The company will use the new funds to scale its busi... |
| 10.10.2022 | Cleon Capital y Columbus Venture Partners anuncian la desinversión en Algenex, adquirida por parte de Insud | 10/10/2022 Nota de prensa CLEON CAPITAL Y COLUMBUS VENTURE PARTNERS ANUNCIAN LA DESINVERSIÓN EN LA COMPAÑÍA BIOTECNOLÓGICA ESPAÑOLA ALGENEX, ADQUIRIDA POR PARTE DE INSUD Los accionistas de Algenex, compañía privada de biotecnología respa... |
| 22.06.2021 | EMA validates Algenex' CrisBio® platform for the manufacturing of vaccines | PRESS RELEASE EMA validates Algenex’ CrisBio® platform for the manufacturing of vaccines Regulator validation supports broad application of insect-based biologics production technology CrisBio offers significant advantages over existing pro... |
| 09.09.2020 | Algenex cierra nueva ronda de €7,4M liderada por MasterLux. Acude Columbus Venture Partners | 09/09/2020 Nota de prensa ALGENEX CIERRA NUEVA RONDA DE €7,4 MILLONES LIDERADA POR MASTERLUX, ACUDE COLUMBUS VENTURE PARTNERS. La compañía biotecnológica Algenex ha cerrado una ronda de financiación privada por valor de 7,4 millones de e... |
| 05.08.2020 | Algenex obtiene €470.000 del CDTI para desarrollar productos para el control y la prevención del COVID-19 | 05/08/2020 Nota de prensa ALGENEX OBTIENE €470.000 DEL CDTI PARA DESARROLLAR PRODUCTOS PARA EL CONTROL Y LA PREVENCIÓN DEL COVID-19. CrisBio®, la disruptiva tecnología de Algenex que utiliza insectos como biorreactores naturales, puede se... |
| 21.03.2019 | Algenex, participada por Uninvest, cierra una nueva ronda de €4M liderada por Cleon Capital y Vita Advisory, acuden business angels | 21/03/2019 Nota de prensa ALGENEX, PARTICIPADA POR UNINVEST, CIERRA UNA NUEVA RONDA DE €4 MILLONES LIDERADA POR CLEON CAPITAL Y VITA ADVISORY, ACUDEN BUSINESS ANGELS. La empresa biotecnológica Algenex, participada por la gestora de entid... |
| 06.03.2019 | Algenex Closes €4M Funding Round | Algenex, a Madrid, Spain-based private biotechnology company delivering technologies for recombinant biologics production, closed an approx. €4M financing round. The round was led by Cleon Capital and Vita Advisory with participation from b... |